drugset / Trial / NCT05798455
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This study investigates the safety and efficacy of sodium pentaborate pentahydrate in patients with advanced renal cell carcinoma.
Timeline
- Start
- 2023-05-22
- Primary completion
- 2025-05-22
- Completion
- 2026-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Pentaborate | Unknown | 500 mg | Oral |
| Subject | Sodium Pentaborate | Unknown | 1000 mg | Oral |
| Subject | Sodium Pentaborate | Unknown | 1500 mg | Oral |